Douglas Slain
Professor
Medicine,Clinical Pharmacy
West Virginia University
United States of America
Biography
Dr. Slain, Pharm.D is currently an Associate Professor at West Virginia University. He received his Pharmacy degree and his Doctor of Pharmacy (Pharm.D.) degree from Duquesne University in Pittsburgh. He then completed a residency and fellowship in infectious diseases pharmacotherapy at the Medical College of Virginia in Richmond. Additionally, he has the distinction of being a Board Certified Pharmacotherapy Specialist (BCPS) with Added Qualifications in Infectious Diseases.Dr. Slain is active at the national level in several infectious diseases and pharmacy associations. Dr. Slain was selected as "Clinician of the Year" by The Society of Infectious Diseases Pharmacists (SIDP). He is WVU’s faculty liaison to two national associations that serve the needs of clinical pharmacy practitioners (The American Society of Health-System Pharmacist (ASHP) and The American College of Clinical Pharmacy (ACCP). He is the program director and principal mentor for the Infectious Diseases Pharmacotherapy Specialized Residency. Dr. Slain’s research has been published in respected peer-reviewed journals. Dr. Slain speaks frequently at regional, national, and international meetings and conferences.
Research Interest
Clinical Pharmacy,medicine
Publications
-
Dong H, Slain D, Cheng J, Ma W, Liang W. Eighteen cases of liver injury following ingestion of Polygonum multiflorum. Complementary therapies in medicine. 2014 Feb 28;22(1):70-4.
-
Turner RB, Smith CB, Martello JL, Slain D. Role of doxycycline in Clostridium difficile infection acquisition. Annals of Pharmacotherapy. 2014 Jun;48(6):772-6.
-
Guarascio AJ, Slain D. Review of the New Delayedâ€Release Oral Tablet and Intravenous Dosage Forms of Posaconazole. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2015 Feb 1;35(2):208-19.
